Doctor profile · Federal record
Dr. Toby Shawe, M.D.
Specialist (CMS: Dermatology) · Wyndmoor, PA
- NPI 1851453765
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 39 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
910 E Willow Grove Ave
Wyndmoor, PA 190387910
(215) 836-7212
fax (215) 836-7715
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- January 10, 2017
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Pennsylvania #MD044018L
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851453765. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
41,958
Distinct HCPCS
10
Medicare allowed
$729,324
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 35,400 | 111 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,171 | 700 | $94 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 909 | 237 | $7 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 789 | 555 | $180 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 773 | 730 | $133 | |
17000 |
Destruction of precancer skin growth, 1 growth | 352 | 310 | $53 | |
11102 |
Biopsy of related skin growth, first growth | 318 | 295 | $91 | |
17110 |
Destruction of skin growth, 1-14 growths | 300 | 268 | $111 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 209 | 61 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 208 | 208 | $117 |
In context: peer comparison
Among 2 peers in Wyndmoor Specialist, average services per provider: 1,264. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$3,241
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 28 | $438.37 | |
| Janssen Biotech, INC. | 23 | $435.04 | |
| Lilly USA, LLC | 14 | $288.10 | |
| Genzyme Corporation | 9 | $278.51 | |
| Sun Pharmaceutical Industries INC. | 8 | $253.63 | |
| Leo Pharma INC. | 11 | $228.51 | |
| Pfizer INC. | 10 | $188.45 | |
| Incyte Corporation | 7 | $168.73 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $166.46 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $133.68 | |
| Amgen INC. | 4 | $122.21 | |
| Regeneron Healthcare Solutions, INC. | 4 | $90.41 | |
| Galderma Laboratories, L.P. | 5 | $87.67 | |
| Dermavant Sciences, INC. | 4 | $79.63 | |
| Arcutis Biotherapeutics, INC. | 3 | $64.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,392
Patients
809
Total drug cost
$73,002
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Minoxidil | Generic | 176 | 67 | $1,771 |
| Fluocinolone Acetonide | Generic | 167 | 77 | $12,689 |
| Triamcinolone Acetonide | Generic | 164 | 115 | $2,457 |
| Ketoconazole | Generic | 127 | 67 | $2,814 |
| Imiquimod | Generic | 122 | 106 | $5,262 |
| Hydrocortisone | Generic | 121 | 88 | $735 |
| Clobetasol Propionate | Generic | 117 | 67 | $10,414 |
| Tavaborole | Generic | 101 | 49 | $17,694 |
| Halobetasol Propionate | Generic | 98 | 73 | $6,077 |
| Doxycycline Hyclate | Generic | 60 | 24 | $5,134 |
Frequently asked questions
What is Dr. Toby Shawe's medical specialty?
Dr. Toby Shawe practices Specialist in Wyndmoor, PA.
Where does Dr. Toby Shawe practice?
Dr. Toby Shawe practices at 910 E Willow Grove Ave, Wyndmoor, PA 190387910. Office phone: 2158367212.
What is Dr. Toby Shawe's NPI?
Dr. Toby Shawe's National Provider Identifier (NPI) is 1851453765, issued by NPPES.
Does Dr. Toby Shawe accept Medicare assignment?
Yes. Dr. Toby Shawe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Toby Shawe commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.